Purple Biotech Ltd.
Develops cancer therapies to overcome tumor immune evasion and drug resistance.
PPBT | TA
Overview
Corporate Details
- ISIN(s):
- IL0007650166
- LEI:
- Country:
- Israel
- Address:
- Oppenheimer 4, 7670104 Rehovot
- Website:
- https://purple-biotech.com/
- Sector:
- Manufacturing
Description
Purple Biotech Ltd. is a clinical-stage company that develops first-in-class therapies for cancer patients. The company focuses on advancing treatments designed to overcome tumor immune evasion and drug resistance, with the goal of providing effective and durable therapeutic solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-04-12 01:26 |
Purple Biotech Presents Positive Interim Phase 1b Study Results for CM24 at the…
|
English | 37.2 KB | ||
| 2022-04-11 16:47 |
presents Positive Interim Phase 1b Study Results for CM24 at the American Assoc…
|
English | 161.3 KB | ||
| 2022-04-11 16:47 |
presents Positive Interim Phase 1b Study Results for CM24 at the American Assoc…
|
English | 36.5 KB | ||
| 2022-04-05 01:22 |
FORM S-8-REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Purple biotech…
|
English | 232.2 KB | ||
| 2022-04-05 01:22 |
FORM S-8-REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Purple biotech…
|
English | 35.9 KB | ||
| 2022-03-24 00:30 |
prospectus supplement originally filed by the Company with the United States
|
English | 97.1 KB | ||
| 2022-03-24 00:30 |
prospectus supplement originally filed by the Company with the United States
|
English | 36.7 KB | ||
| 2022-03-09 14:31 |
Annual report for 2021 on form 20F
|
English | 1.2 MB | ||
| 2022-03-09 14:31 |
Annual report for 2021 on form 20F
|
English | 36.4 KB | ||
| 2022-02-09 15:10 |
results for the year and the six months ended December 31, 2021
|
English | 163.3 KB | ||
| 2022-02-09 15:10 |
results for the year and the six months ended December 31, 2021
|
English | 36.3 KB | ||
| 2022-02-05 22:35 |
Issues Letter to Shareholders
|
English | 6.4 MB | ||
| 2022-02-05 22:35 |
Issues Letter to Shareholders
|
English | 36.4 KB | ||
| 2022-01-06 15:40 |
6K:Purple Biotech Appoints Life Sciences Industry Investor Ori Hershkovitz to i…
|
English | 162.3 KB | ||
| 2022-01-06 15:40 |
6K:Purple Biotech Appoints Life Sciences Industry Investor Ori Hershkovitz to i…
|
English | 36.3 KB |
Automate Your Workflow. Get a real-time feed of all Purple Biotech Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Purple Biotech Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Purple Biotech Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
